Teza Capital Management LLC Sells 15,009 Shares of The Cooper Companies, Inc. $COO

Key Points

• Teza Capital Management LLC significantly reduced its holdings in The Cooper Companies by 79.3%, now owning only 3,912 shares valued at approximately $330,000.
• Cooper Companies reported earnings of $1.10 per share for the last quarter, surpassing analyst expectations of $1.07, with a net margin of 10.08%.
• Analysts are mixed on Cooper Companies' stock, with target prices ranging from $66.00 to $93.00, leading to an average rating of "Moderate Buy."

Teza Capital Management LLC cut its stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 79.3% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,912 shares of the medical device company's stock after selling 15,009 shares during the period. Teza Capital Management LLC's holdings in Cooper Companies were worth $330,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Shell Asset Management Co. boosted its position in Cooper Companies by 15.5% during the fourth quarter. Shell Asset Management Co. now owns 946 shares of the medical device company's stock worth $87,000 after acquiring an additional 127 shares during the last quarter. UMB Bank n.a. raised its stake in shares of Cooper Companies by 16.7% in the 1st quarter. UMB Bank n.a. now owns 902 shares of the medical device company's stock valued at $76,000 after acquiring an additional 129 shares during the period. Horizon Investments LLC increased its stake in Cooper Companies by 5.0% during the 1st quarter. Horizon Investments LLC now owns 2,859 shares of the medical device company's stock worth $241,000 after buying an additional 136 shares during the period. Axxcess Wealth Management LLC increased its stake in Cooper Companies by 1.9% during the 1st quarter. Axxcess Wealth Management LLC now owns 7,382 shares of the medical device company's stock worth $623,000 after buying an additional 140 shares during the period. Finally, Mitchell & Pahl Private Wealth LLC increased its stake in Cooper Companies by 1.8% during the 1st quarter. Mitchell & Pahl Private Wealth LLC now owns 8,675 shares of the medical device company's stock worth $732,000 after buying an additional 157 shares during the period. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

COO has been the subject of several recent analyst reports. JPMorgan Chase & Co. decreased their price objective on shares of Cooper Companies from $76.00 to $66.00 and set a "neutral" rating for the company in a report on Thursday, August 28th. BNP Paribas Exane raised shares of Cooper Companies from a "neutral" rating to an "outperform" rating and set a $92.00 price target for the company in a report on Tuesday, July 22nd. Wall Street Zen lowered shares of Cooper Companies from a "buy" rating to a "hold" rating in a report on Saturday, July 12th. Wells Fargo & Company decreased their price target on shares of Cooper Companies from $93.00 to $72.00 and set an "overweight" rating for the company in a report on Thursday, August 28th. Finally, Morgan Stanley set a $76.00 price target on shares of Cooper Companies and gave the company an "equal weight" rating in a report on Thursday, August 28th. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, Cooper Companies currently has a consensus rating of "Moderate Buy" and an average target price of $86.64.

Cooper Companies Price Performance

Shares of NASDAQ COO traded down $1.78 during midday trading on Friday, reaching $66.68. The company's stock had a trading volume of 3,147,814 shares, compared to its average volume of 3,323,522. The company has a current ratio of 2.12, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29. The company has a 50 day moving average price of $71.53 and a 200 day moving average price of $75.80. The Cooper Companies, Inc. has a one year low of $61.78 and a one year high of $112.38. The company has a market cap of $13.26 billion, a price-to-earnings ratio of 32.85, a price-to-earnings-growth ratio of 1.75 and a beta of 0.97.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its earnings results on Wednesday, August 27th. The medical device company reported $1.10 EPS for the quarter, topping analysts' consensus estimates of $1.07 by $0.03. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The business had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.06 billion. During the same period in the previous year, the firm earned $0.96 EPS. The business's revenue for the quarter was up 5.7% on a year-over-year basis. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. On average, equities research analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Insider Buying and Selling at Cooper Companies

In other news, COO Gerard H. Warner III bought 1,450 shares of the company's stock in a transaction dated Friday, September 5th. The shares were acquired at an average cost of $69.23 per share, with a total value of $100,383.50. Following the completion of the transaction, the chief operating officer directly owned 18,319 shares in the company, valued at approximately $1,268,224.37. The trade was a 8.60% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, COO Daniel G. Mcbride bought 3,000 shares of the company's stock in a transaction dated Tuesday, September 2nd. The stock was purchased at an average cost of $65.04 per share, for a total transaction of $195,120.00. Following the completion of the transaction, the chief operating officer owned 63,120 shares of the company's stock, valued at $4,105,324.80. This represents a 4.99% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired 15,975 shares of company stock valued at $1,079,566 over the last quarter. Company insiders own 1.98% of the company's stock.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.